AnnouncedFiled 24 June 2026
Ollin Biosciences, Inc. raised $156M
Ollin Biosciences, Inc., a biotech company based in Austin, TX, raised $156M in a new equity round, according to a filing dated 24 June 2026.
Announced on 24 June 2026, the day of the filing. ollin.bio ↗
- Filed
- 24 June 2026
- Round
- Equity round
- Amount sold
- $156M
- Offering size
- $330M
- Investors so far
- 32
- Based in
- Austin, TX
- Website
- ollin.bio
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
3 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 95% of the 854 tracked raises with an amount filed in 2026, and than 100% of the 79 in biotech.
Ollin Biosciences, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 24 Jun 2026 | New filing | $156M | This raise |
More with Monograph Capital on the board
Other unannounced rounds
- Thoughtform, Inc.$6.6M
- ProvenAir Technologies, Inc.$488K
- Gravitics, Inc.$17M
- SurgiBox Inc.$486K
- Voxel Labs Inc.$10M
- DVx Atomic Co.$18.5M
Seen it announced?
Send the link and the check will look at it.